What is it about?
Upadacitinib is effective for Patients With Active Ulcerative Colitis
Featured Image
Why is it important?
This publication is the first publication on Upadacitinib is effective for Patients With Active Ulcerative Colitis
Perspectives
Phase 3 trial of Upadacitinib for Patients With Active Ulcerative Colitis is promising
Dr Satoshi Tanida
Nagoya City university
Read the Original
This page is a summary of: Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis, Gastroenterology, February 2020, Elsevier,
DOI: 10.1053/j.gastro.2020.02.030.
You can read the full text:
Contributors
The following have contributed to this page
